Back to Journals » Therapeutics and Clinical Risk Management » Volume 15 » default
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2241)
- Volume 19, 2023 (24)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 15, 2019

Comparative Results Between “Epi-Off” Conventional and Accelerated Corneal Collagen Crosslinking for Progressive Keratoconus in Pediatric Patients
Nicula CA, Rednik AM, Bulboacă AE, Nicula D
Therapeutics and Clinical Risk Management 2019, 15:1483-1490
Published Date: 30 December 2019

It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
Migliore A, Gigliucci G, Petrella RJ, Bannuru RR, Chevalier X, Maheu E, Raman R, Herrero-Beaumont G, Isailovic N, Matucci Cerinc M
Therapeutics and Clinical Risk Management 2019, 15:1479-1482
Published Date: 23 December 2019

Therapeutic Approaches to Gastric Hepatoid Adenocarcinoma: Current Perspectives
Søreide JA
Therapeutics and Clinical Risk Management 2019, 15:1469-1477
Published Date: 23 December 2019

Combined Direct Posterior Split-Gastrocnemius Approach for the Posterolateral Tibial Plateau Involved Fractures
Chen C, Huang L, Zheng H, Liu L, Chen Y, Xie X, Wang Y
Therapeutics and Clinical Risk Management 2019, 15:1461-1467
Published Date: 19 December 2019

Intraoperative Urine Output Is Associated with Postoperative Outcome in Pediatric Population Undergone Major Abdominal Operations
Zheng C, Guo C
Therapeutics and Clinical Risk Management 2019, 15:1453-1460
Published Date: 18 December 2019

Acute Intermittent Porphyria: Current Perspectives And Case Presentation
Spiritos Z, Salvador S, Mosquera D, Wilder J
Therapeutics and Clinical Risk Management 2019, 15:1443-1451
Published Date: 16 December 2019

Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)
Argula RG, Ward C, Feghali-Bostwick C
Therapeutics and Clinical Risk Management 2019, 15:1427-1442
Published Date: 13 December 2019

Increased Surgical Duration Associated With Prolonged Hospital Stay After Isolated Posterior Cruciate Ligament Reconstruction
Swindell HW, Boddapati V, Sonnenfeld JJ, Trofa DP, Fleischli JE, Ahmad CS, Popkin CA
Therapeutics and Clinical Risk Management 2019, 15:1417-1425
Published Date: 10 December 2019

Unusual Presentation Of Kawasaki Disease With Gastrointestinal And Renal Manifestations
Lazea C, Man O, Sur LM, Serban R, Lazar C
Therapeutics and Clinical Risk Management 2019, 15:1411-1416
Published Date: 5 December 2019

The Effect of Coenzyme Q10 Supplementation on Vascular Endothelial Growth Factor and Serum Levels of Interleukin 6 and 8 in Women with Breast Cancer: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Zahrooni N, Hosseini SA, Ahmadzadeh A, Ahmadi Angali K, Assarehzadegan MA
Therapeutics and Clinical Risk Management 2019, 15:1403-1410
Published Date: 4 December 2019

Severe Atopic Dermatitis In Spain: A Real-Life Observational Study
Sicras-Mainar A, Navarro-Artieda R, Armario-Hita JC
Therapeutics and Clinical Risk Management 2019, 15:1393-1401
Published Date: 2 December 2019

Hepatorenal Syndrome Type 1: Current Challenges And Future Prospects
Facciorusso A
Therapeutics and Clinical Risk Management 2019, 15:1383-1391
Published Date: 27 November 2019
Comparison Of Three Different Treatment Methods For Cesarean Scar Pregnancy
Fei H, Jiang X, Li T, Pan Y, Guo H, Xu X, Shu S
Therapeutics and Clinical Risk Management 2019, 15:1377-1381
Published Date: 27 November 2019

Functional BDNF rs7124442 Variant Regulated by miR-922 is Associated with Better Short-Term Recovery of Ischemic Stroke
Liu B, He W, Liu D
Therapeutics and Clinical Risk Management 2019, 15:1369-1375
Published Date: 20 November 2019

Gamma Knife Radiosurgery For Brain Vascular Malformations: Current Evidence And Future Tasks
Hasegawa H, Yamamoto M, Shin M, Barfod BE
Therapeutics and Clinical Risk Management 2019, 15:1351-1367
Published Date: 18 November 2019

Incidence Of Clostridium difficile Infection And Associated Risk Factors Among Hospitalized Children In Qatar
Khalil A, Hendaus MA, Elmagboul E, Mohamed A, Deshmukh A, Elmasoudi A
Therapeutics and Clinical Risk Management 2019, 15:1343-1350
Published Date: 18 November 2019

Analysis Of Re-Hospitalizations For Patients With Heart Failure Caused By Coronary Heart Disease: Data Of First Event And Recurrent Event
Tian J, Yan J, Zhang Q, Yang H, Chen X, Han Q, Han R, Ren J, Zhang Y, Han Q
Therapeutics and Clinical Risk Management 2019, 15:1333-1341
Published Date: 14 November 2019

Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Was Modified
Baum SJ, Wade RL, Xiang P, Arellano J, Cerezo Olmos C, Nunna S, Chen CC, Carter CM, Desai NR
Therapeutics and Clinical Risk Management 2019, 15:1325-1332
Published Date: 13 November 2019

Combined Corneal Wedge Resection And Corneal Cross-Linking For Pellucid Marginal Degeneration: A First Report

Kymionis G, Voulgari N, Samutelela E, Kontadakis G, Tabibian D
Therapeutics and Clinical Risk Management 2019, 15:1319-1324
Published Date: 12 November 2019

Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm

Wang Y, Patel A, Douglas RS
Therapeutics and Clinical Risk Management 2019, 15:1305-1318
Published Date: 11 November 2019

Predictors Of Postoperative Lower Urinary Tract Symptoms Improvements In Patient With Small-Volume Prostate And Bladder Outlet Obstruction
Li XD, Wu YP, Ke ZB, Lin TT, Chen SH, Xue XY, Xu N, Wei Y
Therapeutics and Clinical Risk Management 2019, 15:1291-1304
Published Date: 7 November 2019

Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review

Yasuda Y, Nagano T, Tachihara M, Chihara N, Umezawa K, Katsurada N, Yamamoto M, Sekiguchi K, Kobayashi K, Nishimura Y
Therapeutics and Clinical Risk Management 2019, 15:1283-1289
Published Date: 1 November 2019

Randomized Controlled Trial Of Lichtenstein Repair Of Indirect Inguinal Hernias With Two Biologic Meshes From Porcine Small Intestine Submucosa
Sun L, Chen J, Shen Y
Therapeutics and Clinical Risk Management 2019, 15:1277-1282
Published Date: 31 October 2019

Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations
Baharudin A, Abdul Latiff AH, Woo K, Yap FBB, Tang IP, Leong KF, Chin WS, Wang DY
Therapeutics and Clinical Risk Management 2019, 15:1267-1275
Published Date: 31 October 2019


Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review


Naito T
Therapeutics and Clinical Risk Management 2019, 15:1253-1266
Published Date: 29 October 2019

Influence Of Uncertainty, Depression, And Social Support On Self-Care Compliance In Hemodialysis Patients
Kim B, Kim J
Therapeutics and Clinical Risk Management 2019, 15:1243-1251
Published Date: 22 October 2019

Clinical Outcomes And Risk Factors In Patients Circumcised By Chinese Shang Ring: A Prospective Study Based On Age And Types Of Penile Disease
Wang H, Huang Z, Zhou J, Zhang X, Liang C
Therapeutics and Clinical Risk Management 2019, 15:1233-1241
Published Date: 21 October 2019

Frailty In Patients Undergoing Vascular Surgery: A Narrative Review Of Current Evidence
Czobor NR, Lehot JJ, Holndonner-Kirst E, Tully PJ, Gal J, Szekely A
Therapeutics and Clinical Risk Management 2019, 15:1217-1232
Published Date: 17 October 2019

Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients
Huang CC, Charng MJ
Therapeutics and Clinical Risk Management 2019, 15:1209-1216
Published Date: 15 October 2019
Profile Of Tezacaftor/Ivacaftor Combination And Its Potential In The Treatment Of Cystic Fibrosis [Erratum]
Shiferaw D, Faruqi S
Therapeutics and Clinical Risk Management 2019, 15:1207-1208
Published Date: 11 October 2019

Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases
Cho IY
Therapeutics and Clinical Risk Management 2019, 15:1183-1206
Published Date: 8 October 2019

External Validation Of The Surgical Mortality Probability Model (S-MPM) In Patients Undergoing Non-Cardiac Surgery
Kazimierczak S, Rybicka A, Strauss J, Schram M, Kazimierczak A, Grochans E
Therapeutics and Clinical Risk Management 2019, 15:1173-1182
Published Date: 4 October 2019

Use Of Regional Anesthesia For Lower Extremity Amputation May Reduce The Need For Perioperative Vasopressors: A Propensity Score-Matched Observational Study
Kim SJ, Kim N, Kim EH, Roh YH, Song J, Park KH, Choi YS
Therapeutics and Clinical Risk Management 2019, 15:1163-1171
Published Date: 2 October 2019

Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
Dangouloff T, Servais L
Therapeutics and Clinical Risk Management 2019, 15:1153-1161
Published Date: 2 October 2019

Clinical Pathways For Pancreatic Surgery: Are They A Suitable Instrument For Process Standardization To Improve Process And Outcome Quality Of Patients Undergoing Distal And Total Pancreatectomy? - A Retrospective Cohort Study
Téoule P, Römling L, Schwarzbach M, Birgin E, Rückert F, Wilhelm TJ, Niedergethmann M, Post S, Rahbari NN, Reißfelder C, Ronellenfitsch U
Therapeutics and Clinical Risk Management 2019, 15:1141-1152
Published Date: 1 October 2019

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
Xie W, Luo Y, Liang X, Lin Z, Wang Z, Liu M
Therapeutics and Clinical Risk Management 2019, 15:1129-1140
Published Date: 24 September 2019

A comparison of McGrath MAC, Pentax AWS, and Macintosh direct laryngoscopes for nasotracheal intubation: a randomized controlled trial
Chae YJ, Kim DH, Park EJ, Oh J, Yi IK
Therapeutics and Clinical Risk Management 2019, 15:1121-1128
Published Date: 18 September 2019

Photosensitivity reactions in the elderly population: questionnaire-based survey and literature review
Korzeniowska K, Cieślewicz A, Chmara E, Jabłecka A, Pawlaczyk M
Therapeutics and Clinical Risk Management 2019, 15:1111-1119
Published Date: 12 September 2019

Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence
Korzeniowska K, Jankowski J, Cieślewicz A, Jabłecka A
Therapeutics and Clinical Risk Management 2019, 15:1095-1110
Published Date: 9 September 2019

Idiopathic pulmonary fibrosis and GERD: links and risks
Ghisa M, Marinelli C, Savarino V, Savarino E
Therapeutics and Clinical Risk Management 2019, 15:1081-1093
Published Date: 5 September 2019

Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis
Pelechas E, Voulgari PV, Drosos AA
Therapeutics and Clinical Risk Management 2019, 15:1073-1079
Published Date: 4 September 2019

Atherosclerosis risk assessment in patients with chronic obstructive pulmonary disease: a case-control study
Sharma H, Kapur P, Jalali RK, Dubey K
Therapeutics and Clinical Risk Management 2019, 15:1061-1071
Published Date: 29 August 2019

Multivariate analysis of poor outcome after anterior surgery in multilevel cervical spondylotic myelopathy patients with heterotopic ossification and preoperative kyphotic alignment
Li S, Zhang B, Shen Y, Wu Z
Therapeutics and Clinical Risk Management 2019, 15:1053-1060
Published Date: 27 August 2019

Autosomal dominant polycystic kidney disease: updated perspectives
Rastogi A, Ameen KM, Al-Baghdadi M, Shaffer K, Nobakht N, Kamgar M, Lerma EV
Therapeutics and Clinical Risk Management 2019, 15:1041-1052
Published Date: 26 August 2019

Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis
Shiferaw D, Faruqi S
Therapeutics and Clinical Risk Management 2019, 15:1029-1040
Published Date: 22 August 2019

Trends and correlation of antibiotic susceptibility and antibiotic consumption at a large teaching hospital in China (2007–2016): a surveillance study
Wang R, Yang Q, Zhang S, Hong Y, Zhang M, Jiang S
Therapeutics and Clinical Risk Management 2019, 15:1019-1027
Published Date: 20 August 2019

The potential risk factors of cortical visual impairment following cerebral angiography: a retrospective study
Yang Y, Zhang J, Li T
Therapeutics and Clinical Risk Management 2019, 15:1013-1017
Published Date: 19 August 2019

Multidirectional percutaneous drilling and autologous bone marrow injection for the treatment of femoral diaphyseal nonunions: a prospective interventional study
Li M, Meng Y, Li Y, Long A, Lv H, Yin P, Zhang L, Tang P
Therapeutics and Clinical Risk Management 2019, 15:1003-1011
Published Date: 19 August 2019

The determinants of obstetricians’ willingness to undertake delivery by vaginal birth after cesarean section in Taiwan
Linn G, Ying Y, Chang K
Therapeutics and Clinical Risk Management 2019, 15:991-1002
Published Date: 13 August 2019

Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients
Dai J, Zhao J, Du Y, McNeil EB, Chongsuvivatwong V
Therapeutics and Clinical Risk Management 2019, 15:979-989
Published Date: 8 August 2019

The importance of early identification of infusion-related reactions to monoclonal antibodies
Cáceres MC, Guerrero-Martín J, Pérez-Civantos D, Palomo-López P, Delgado-Mingorance JI, Durán-Gómez N
Therapeutics and Clinical Risk Management 2019, 15:965-977
Published Date: 1 August 2019

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
Beiko T, Strange C
Therapeutics and Clinical Risk Management 2019, 15:959-964
Published Date: 31 July 2019
Tracheal intubation with the rigid tube for laryngoscopy – a new method [Retraction]
Marchis IF, Radeanu D, Cosgarea M
Therapeutics and Clinical Risk Management 2019, 15:957-958
Published Date: 29 July 2019

Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives
Overwater IE, Rietman AB, van Eeghen AM, de Wit MCY
Therapeutics and Clinical Risk Management 2019, 15:951-955
Published Date: 26 July 2019
Gastric duplication 20 years after a partial distal gastrectomy: a case report and review of literature
Feng Y, Ye JN, Chen CQ, Zhang XH
Therapeutics and Clinical Risk Management 2019, 15:943-949
Published Date: 29 July 2019

Glioma-associated radiation retinopathy treated successfully with aflibercept
Karagiannis D, Kontomichos L, Georgalas I, Peponis V, Antoniou E, Parikakis E
Therapeutics and Clinical Risk Management 2019, 15:937-941
Published Date: 26 July 2019

The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies
Abu Mellal A, Hussain N, Said ASA
Therapeutics and Clinical Risk Management 2019, 15:921-936
Published Date: 23 July 2019

Neutrophil–lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study
Zhang Y, Zou P, Gao H, Yang M, Yi P, Gan J, Shen Y, Wang W, Zhang W, Li J, Liu P, Li L
Therapeutics and Clinical Risk Management 2019, 15:911-919
Published Date: 24 July 2019

Corpus callosotomy might have reduced epileptic seizure-induced repetitive shoulder joint dislocation in two patients with medically intractable epilepsy who were not focus resection candidates

Sakakura K, Fujimoto A, Ichikawa N, Sato K, Enoki H, Okanishi T
Therapeutics and Clinical Risk Management 2019, 15:905-909
Published Date: 22 July 2019

Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis
Goischke HK
Therapeutics and Clinical Risk Management 2019, 15:891-904
Published Date: 12 July 2019

Fentanyl vs fentanyl-dexmedetomidine in lumbar foraminotomy surgery
Abdul Hadi B, Sbeitan SM, Shakya AK
Therapeutics and Clinical Risk Management 2019, 15:885-890
Published Date: 15 July 2019

Histological type of focal cortical dysplasia is associated with the risk of postsurgical seizure in children and adolescents
Chen J, Huang Z, Li L, Ren L, Wang Y
Therapeutics and Clinical Risk Management 2019, 15:877-884
Published Date: 11 July 2019

A case of chronic eosinophilic pneumonia in a patient treated with dupilumab
Menzella F, Montanari G, Patricelli G, Cavazza A, Galeone C, Ruggiero P, Bagnasco D, Facciolongo N
Therapeutics and Clinical Risk Management 2019, 15:869-875
Published Date: 10 July 2019

SGLT2 inhibitors and the changing landscape for treatment of diabetes
Liu S, Lam A, Wazir A, Cheema AN
Therapeutics and Clinical Risk Management 2019, 15:861-867
Published Date: 9 July 2019

Predictors of postoperative outcomes in infants with low birth weight undergoing congenital heart surgery: a retrospective observational study
Lu C, Yu L, Wei J, Chen J, Zhuang J, Wang S
Therapeutics and Clinical Risk Management 2019, 15:851-860
Published Date: 9 July 2019

Explorative analysis of gender-specific characteristics in patients with heart failure in an Italian hospital
Perrone V, Veronesi C, Nica M, Colombo D, Degli Esposti L, Castello R
Therapeutics and Clinical Risk Management 2019, 15:847-850
Published Date: 8 July 2019

Measuring serum beta2-microglobulin to predict long-term mortality in hemodialysis patients using low-flux dialyzer reuse
Dung NH, Kien NT, Hai NTT, Cuong PT, Huong NTT, Quyen DBQ, Tuan NM, Ha DM, Kien TQ, Dung NTT, Toan PQ, Vinh HT, Usui T, Thang LV
Therapeutics and Clinical Risk Management 2019, 15:839-846
Published Date: 9 July 2019

Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?
Németh B, Péter I, Boncz I, Jagicza A, Kiss I, Csergő Á, Kőszegi T, Kustán P, Horváth IG, Ajtay Z
Therapeutics and Clinical Risk Management 2019, 15:831-837
Published Date: 5 July 2019

The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions
Ciloglu E, Yıldırım Celikdemir A
Therapeutics and Clinical Risk Management 2019, 15:823-830
Published Date: 4 July 2019

Higher serum total bilirubin predicts high risk of 3-year adverse outcomes in patients undergoing primary percutaneous coronary intervention
Gao F, Qiang H, Fan XJ, Xue Q, Bai L
Therapeutics and Clinical Risk Management 2019, 15:811-821
Published Date: 1 July 2019

Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis
Zhang H, Wu J, Zhang Z, Qian H, Wang Y, Yang M, Cheng Y, Tang S
Therapeutics and Clinical Risk Management 2019, 15:803-810
Published Date: 27 June 2019

Current status of venous thromboembolism development during the perioperative period for colorectal cancer, its prevention with enoxaparin, and monitoring methods
Aoki J, Sakamoto K, Takahashi R, Niwa K, Ishiyama S, Sugimoto K, Kamiyama H, Takahashi M, Kojima Y, Goto M, Tomiki Y, Iba T
Therapeutics and Clinical Risk Management 2019, 15:791-802
Published Date: 21 June 2019

Antibiotic overuse and allergy-related diseases: an epidemiological cross-sectional study in the grasslands of Northern China
Chen YL, Sng WJ, Wang DY, Wang XY
Therapeutics and Clinical Risk Management 2019, 15:783-789
Published Date: 21 June 2019

Analgesia and sedation post-coronary artery bypass graft surgery: a review of the literature
Jannati M, Attar A
Therapeutics and Clinical Risk Management 2019, 15:773-781
Published Date: 20 June 2019

Use of levosimendan in acute and advanced heart failure: short review on available real-world data
Pashkovetsky E, Gupta CA, Aronow WS
Therapeutics and Clinical Risk Management 2019, 15:765-772
Published Date: 17 June 2019

Comparison of ketamine-propofol mixture (ketofol) and midazolam-meperidine in endoscopic retrograde cholangiopancretography (ERCP) for oldest old patients
Ebru TK, Resul K
Therapeutics and Clinical Risk Management 2019, 15:755-763
Published Date: 18 June 2019

The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis
Zhu Y, Li X, Guo P, Chen Y, Li J, Tao T
Therapeutics and Clinical Risk Management 2019, 15:741-753
Published Date: 13 June 2019

Presepsin level in predicting patients’ in-hospital mortality from sepsis under sepsis-3 criteria
Wen MY, Huang LQ, Yang F, Ye JK, Cai GX, Li XS, Ding HG, Zeng HK
Therapeutics and Clinical Risk Management 2019, 15:733-739
Published Date: 13 June 2019

Retroperitoneal robot-assisted laparoscopic upper pole heminephrectomy in adult patients with duplex kidneys
Qin J, Wang P, Jing T, Kong D, Ye S, Xia D, Wang S
Therapeutics and Clinical Risk Management 2019, 15:727-731
Published Date: 11 June 2019

Benign paroxsymal positional vertigo – recommendations for treatment in primary care
Wang YH, Chan CY, Liu QH
Therapeutics and Clinical Risk Management 2019, 15:719-725
Published Date: 11 June 2019

Ultrasound-guided percutaneous carpal tunnel release in patients on hemodialysis: early experiences and clinical outcomes
Wang PH, Li CL, Shao CJ, Wu KC, Chern TC, Jou IM
Therapeutics and Clinical Risk Management 2019, 15:711-717
Published Date: 10 June 2019

The radial augmentation index in children with Kawasaki disease without acute coronary artery lesions during the convalescent period
Zheng J, Nakamura T, Lu N, Hori K, Oguri M, Sakurai M, Ishizaki M
Therapeutics and Clinical Risk Management 2019, 15:701-709
Published Date: 12 June 2019
Overnight inpatient admission and revisit rates after pediatric adenotonsillectomy
Alsuhebani M, Walia H, Miller R, Elmaraghy C, Tumin D, Tobias JD, Raman VT
Therapeutics and Clinical Risk Management 2019, 15:689-699
Published Date: 6 June 2019

Improved perioperative quality of life in endoscopic sinus surgery by application of enhanced recovery after surgery
Wu X, Kong W, Zhu Q, Wang W, Xu H, Zhou S, Yang Q
Therapeutics and Clinical Risk Management 2019, 15:683-688
Published Date: 4 June 2019

External ventricular drainage combined with continuous lumbar drainage in the treatment of ventricular hemorrhage
Xia D, Jiang X, Li Z, Jin Y, Dai Y
Therapeutics and Clinical Risk Management 2019, 15:677-682
Published Date: 30 May 2019

Prediction of difficult airway management in traumatic cervical spine injury: influence of retropharyngeal space extension

Lee J, Kim JS, Kang S, Shin YS, Doo AR
Therapeutics and Clinical Risk Management 2019, 15:669-675
Published Date: 17 May 2019

Improvement of energy substrate metabolism by late evening snack supplementation in patients with liver cirrhosis: a meta-analysis
Yao J, Han W, Ren X, Yuan L, Xu J, Duan Z
Therapeutics and Clinical Risk Management 2019, 15:659-668
Published Date: 15 May 2019

Usefulness of bounce-back admission in monitoring the quality of practice in the emergency department
Tarumi Y, Harada T, Saito T, Hiroshige J, Dohi K
Therapeutics and Clinical Risk Management 2019, 15:647-658
Published Date: 6 May 2019

Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis
Drokow EK, Ahmed HAW, Amponsem-Boateng C, Akpabla GS, Song J, Shi M, Sun K
Therapeutics and Clinical Risk Management 2019, 15:637-646
Published Date: 6 May 2019

Dexmedetomidine reduces sevoflurane EC50 for supraglottic airway device insertion in spontaneously breathing morbidly obese patients
Wan L, Shao LJZ, Liu Y, Wang HX, Xue FS, Tian M
Therapeutics and Clinical Risk Management 2019, 15:627-635
Published Date: 3 May 2019

Rivaroxaban in atrial fibrillation cardioversion: an update
Lavalle C, Straito M, Caroli A, Piro A, Giunta G, Mariani MV, Fedele F
Therapeutics and Clinical Risk Management 2019, 15:613-626
Published Date: 2 May 2019

Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M
Therapeutics and Clinical Risk Management 2019, 15:605-612
Published Date: 1 May 2019

Total knee arthroplasty associated with tibial tubercle and simultaneous femoral and tibial osteotomies for severe extra-articular deformity: a case report
Sponer P, Kucera T
Therapeutics and Clinical Risk Management 2019, 15:597-603
Published Date: 1 May 2019

Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis
Leelawattanachai P, Montakantikul P, Nosoongnoen W, Chayakulkeeree M
Therapeutics and Clinical Risk Management 2019, 15:589-595
Published Date: 24 April 2019


Frequency of nonaspirin NSAID-relevant coexisting medical conditions in the primary-care setting: a retrospective database review
Bloom L, Boyle KE, Myers AE, Blacketer C, Weinstein R
Therapeutics and Clinical Risk Management 2019, 15:579-588
Published Date: 24 April 2019

Effect of using the Suction Above Cuff Endotracheal Tube (SACETT) on postoperative respiratory complications in rhinoplasty: a randomized prospective controlled trial
Yuzkat N, Demir CY
Therapeutics and Clinical Risk Management 2019, 15:571-577
Published Date: 17 April 2019

Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy
Lupi C, Guerzoni S, Negro A, Benemei S
Therapeutics and Clinical Risk Management 2019, 15:557-569
Published Date: 11 April 2019

Interprofessional safety reporting and review of adverse events and medication errors in critical care
Chapuis C, Chanoine S, Colombet L, Calvino-Gunther S, Tournegros C, Terzi N, Bedouch P, Schwebel C
Therapeutics and Clinical Risk Management 2019, 15:549-556
Published Date: 2 April 2019

Associated factors for depressive disorder in patients with end-stage renal disease treated with continuous ambulatory peritoneal dialysis
Traisathit P, Moolkham K, Maneeton N, Thongsak N, Maneeton B
Therapeutics and Clinical Risk Management 2019, 15:541-548
Published Date: 1 April 2019

Safety and efficacy of cervical disc arthroplasty in preventing the adjacent segment disease: a meta-analysis of mid- to long-term outcomes in prospective, randomized, controlled multicenter studies
Latka D, Kozlowska K, Miekisiak G, Latka K, Chowaniec J, Olbrycht T, Latka M
Therapeutics and Clinical Risk Management 2019, 15:531-539
Published Date: 28 March 2019

Fosfomycin: the characteristics, activity, and use in critical care
Hashemian SMR, Farhadi Z, Farhadi T
Therapeutics and Clinical Risk Management 2019, 15:525-530
Published Date: 27 March 2019

Drug-related problems in patients with rheumatoid arthritis
Ma SN, Zaman Huri H, Yahya F
Therapeutics and Clinical Risk Management 2019, 15:505-524
Published Date: 21 March 2019

Pretransplant metabolic syndrome and its components predict post-transplantation diabetes mellitus in Chinese patients receiving a first renal transplant
Cai R, Wu M, Xing YF
Therapeutics and Clinical Risk Management 2019, 15:497-503
Published Date: 14 March 2019

Hybrid graft vs autograft in anterior cruciate ligament reconstruction: a meta-analysis
Wang L, Cao JG, Liu J
Therapeutics and Clinical Risk Management 2019, 15:487-495
Published Date: 14 March 2019



Future perspectives of anticholinergics for the treatment of asthma in adults and children


Buhl R, Hamelmann E
Therapeutics and Clinical Risk Management 2019, 15:473-485
Published Date: 14 March 2019



Choosing the right inhaler for your asthma or COPD patient


Usmani OS
Therapeutics and Clinical Risk Management 2019, 15:461-472
Published Date: 14 March 2019



Preschool children with persistent asthmatic symptoms


Vogelberg C
Therapeutics and Clinical Risk Management 2019, 15:451-460
Published Date: 14 March 2019



Clinical efficacy and safety of anticholinergic therapies in pediatric patients


Goldstein S
Therapeutics and Clinical Risk Management 2019, 15:437-449
Published Date: 14 March 2019



Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies


Jenkins C
Therapeutics and Clinical Risk Management 2019, 15:423-435
Published Date: 14 March 2019



Unmet needs in asthma


Gruffydd-Jones K
Therapeutics and Clinical Risk Management 2019, 15:409-421
Published Date: 14 March 2019


Anticholinergics in asthma: are we utilizing asthma therapies effectively?
Vogelberg C
Therapeutics and Clinical Risk Management 2019, 15:405-408
Published Date: 14 March 2019

Chronic eosinophilic pneumonia: clinical perspectives

Crowe M, Robinson D, Sagar M, Chen L, Ghamande S
Therapeutics and Clinical Risk Management 2019, 15:397-403
Published Date: 13 March 2019

Incidence, clinical features, and risk factors of fluoroquinolone-induced acute liver injury: a case-control study
Yang HY, Guo DH, Jia WP, Zhu M, Xu YJ, Wang XY
Therapeutics and Clinical Risk Management 2019, 15:389-395
Published Date: 8 March 2019

Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation
Kim HC, Kim TH, Rhee CK, Han M, Oh YM
Therapeutics and Clinical Risk Management 2019, 15:377-387
Published Date: 5 March 2019

Comprehensive evaluation of Manikin-based airway training with second generation supraglottic airway devices

Schmutz A, Bohn E, Spaeth J, Heinrich S
Therapeutics and Clinical Risk Management 2019, 15:367-376
Published Date: 1 March 2019

Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan
DiBonaventura MD, Shah-Manek B, Higginbottom K, Penrod JR, Yuan Y
Therapeutics and Clinical Risk Management 2019, 15:355-366
Published Date: 28 February 2019

Treatment with Saccharomyces boulardii and Escherichia coli Nissle is safe and associated with reduced nosocomial transmission of vanB vancomycin-resistant Enterococcus faecium on an early rehabilitation ward in Germany: a retrospective analysis
Borgmann S, Rieß B, Siegmund R, Werner G, Klare I
Therapeutics and Clinical Risk Management 2019, 15:343-354
Published Date: 27 February 2019

Retention of aberrant cortisol secretion in a patient with bilateral macronodular adrenal hyperplasia after unilateral adrenalectomy

Tanaka S, Fujishiro M, Nakamura Y, Hatanaka Y, Abe M
Therapeutics and Clinical Risk Management 2019, 15:337-342
Published Date: 27 February 2019

Current approaches in the grading and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy
Riegler LL, Jones GP, Lee DW
Therapeutics and Clinical Risk Management 2019, 15:323-335
Published Date: 28 February 2019

Use of National Early Warning Score for observation for increased risk for clinical deterioration during post-ICU care at a surgical ward
Klepstad PK, Nordseth T, Sikora N, Klepstad P
Therapeutics and Clinical Risk Management 2019, 15:315-322
Published Date: 25 February 2019

Tracheal intubation with the rigid tube for laryngoscopy – a new method

Marchis IF, Radeanu D, Cosgarea M
Therapeutics and Clinical Risk Management 2019, 15:309-313
Published Date: 25 February 2019

Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report

Uehara M, Nakamura Y, Takahashi J, Suzuki T, Iijima M, Arakawa Y, Ida K, Kosho T, Kato H
Therapeutics and Clinical Risk Management 2019, 15:303-307
Published Date: 25 February 2019

Risk and incidence of fatal adverse events associated with immune checkpoint inhibitors: a systematic review and meta-analysis
Jiang Y, Zhang N, Pang H, Gao X, Zhang H
Therapeutics and Clinical Risk Management 2019, 15:293-302
Published Date: 15 February 2019

Association of endothelial function with thin-cap fibroatheroma as assessed by optical coherence tomography in patients with acute coronary syndromes
Matsuzawa Y, Hibi K, Saka K, Konishi M, Akiyama E, Nakayama N, Ebina T, Kosuge M, Iwahashi N, Maejima N, Tamura K, Kimura K
Therapeutics and Clinical Risk Management 2019, 15:285-291
Published Date: 15 February 2019

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib
Kawalec P, Śladowska K, Malinowska-Lipień I, Brzostek T, Kózka M
Therapeutics and Clinical Risk Management 2019, 15:275-284
Published Date: 13 February 2019

Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
Elbedewy TA, Elsebaey MA, Elshweikh SA, Elashry H, Abd-Elsalam S
Therapeutics and Clinical Risk Management 2019, 15:269-274
Published Date: 11 February 2019

Implications from China patient safety incidents reporting system
Gao XQ, Yan SP, Wu WQ, Zhang R, Lu YL, Xiao SY
Therapeutics and Clinical Risk Management 2019, 15:259-267
Published Date: 8 February 2019

Impact of ST-segment elevation on the outcome of Takotsubo syndrome
Gietzen T, El-Battrawy I, Lang S, Zhou X, Behnes M, Ansari U, Borggrefe M, Akin I
Therapeutics and Clinical Risk Management 2019, 15:251-258
Published Date: 7 February 2019

Well leg compartment syndrome in trauma surgery – femoral shaft fracture treated by femoral intramedullary nailing in the hemilithotomy position: case series and review of the literature
Brouze IF, Steinmetz S, McManus J, Borens O
Therapeutics and Clinical Risk Management 2019, 15:241-250
Published Date: 8 February 2019

The features of cerebral permeability and perfusion detected by dynamic contrast-enhanced magnetic resonance imaging with Patlak model in relapsing–remitting multiple sclerosis
Xiong H, Yin P, Li X, Yang C, Zhang D, Huang X, Tang Z
Therapeutics and Clinical Risk Management 2019, 15:233-240
Published Date: 4 February 2019

Risk factors of postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer
Yang R, Wu Y, Yao L, Xu J, Zhang S, Du C, Chen F
Therapeutics and Clinical Risk Management 2019, 15:223-231
Published Date: 4 February 2019

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
Zhou S, Khanal S, Zhang H
Therapeutics and Clinical Risk Management 2019, 15:211-221
Published Date: 31 January 2019

Physical function assessment of older adults with lower body fractures at 3 months post-discharge from hospital
Ibrahim NI, Sharkawi Ahmad M, Zulfarina MS, Zaris SNASM, Nor Azlin ZA, Naina Mohamed I, Mohamed N, Mokhtar SA, Shuid AN
Therapeutics and Clinical Risk Management 2019, 15:201-210
Published Date: 29 January 2019

Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis
Tian S, Li R, Guo Y, Jia X, Dong W
Therapeutics and Clinical Risk Management 2019, 15:191-200
Published Date: 29 January 2019

A good first step for ERAS in otolaryngoiatric field, but not enough
Pelli M, Maggi L, Rocco M
Therapeutics and Clinical Risk Management 2019, 15:187-189
Published Date: 25 January 2019

Robotic single-site surgery for mature cyst teratoma cystectomy: an initial case series study in a single medical center in China

Liu Z, Tian S, Yan Z, Yu X, Li X, Tao Y
Therapeutics and Clinical Risk Management 2019, 15:179-185
Published Date: 24 January 2019

Uterine fibroids: an update on current and emerging medical treatment options
Farris M, Bastianelli C, Rosato E, Brosens I, Benagiano G
Therapeutics and Clinical Risk Management 2019, 15:157-178
Published Date: 23 January 2019

New therapies for the treatment of heart failure: a summary of recent accomplishments
Machaj F, Dembowska E, Rosik J, Szostak B, Mazurek-Mochol M, Pawlik A
Therapeutics and Clinical Risk Management 2019, 15:147-155
Published Date: 22 January 2019


Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings


Elnaem MH, Nik Mohamed MH, Huri HZ, Mohd Shah AS
Therapeutics and Clinical Risk Management 2019, 15:137-145
Published Date: 18 January 2019

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination
Yu HH, Yonemura Y, Hsieh MC, Lu CY, Wu SY, Shan YS
Therapeutics and Clinical Risk Management 2019, 15:129-136
Published Date: 14 January 2019

Clinical outcomes and risk factors in patients with cervical metastatic spinal cord compression after posterior decompressive and spinal stabilization surgery

Lei M, Yu J, Yan S, An X, Liu Y
Therapeutics and Clinical Risk Management 2019, 15:119-127
Published Date: 11 January 2019

Investigation of prostate resected weight on postoperative sexual dysfunction following transurethral resection of prostate surgery: a population-based study
Liu FC, Shen SJ, Lin JR, Yu HP
Therapeutics and Clinical Risk Management 2019, 15:113-118
Published Date: 10 January 2019

Amiodarone and risk of liver cirrhosis: a nationwide, population-based study
Huang CH, Lai YY, Kuo YJ, Yang SC, Chang YJ, Chang KK, Chen WK
Therapeutics and Clinical Risk Management 2019, 15:103-112
Published Date: 10 January 2019

Comparison of endoscopic papillary large balloon dilation with and without a prior endoscopic sphincterotomy for the treatment of patients with large and/or multiple common bile duct stones: a systematic review and meta-analysis
Liu P, Lin H, Chen Y, Wu Y, Tang M, Lai L
Therapeutics and Clinical Risk Management 2019, 15:91-101
Published Date: 9 January 2019

Analysis on clinical effects of dilation and curettage guided by ultrasonography versus hysteroscopy after uterine artery embolization in the treatment of cesarean scar pregnancy
Qiu J, Fu Y, Xu J, Huang X, Yao G, Lu W
Therapeutics and Clinical Risk Management 2019, 15:83-89
Published Date: 7 January 2019

Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
Moua T, Ryu JH
Therapeutics and Clinical Risk Management 2019, 15:73-81
Published Date: 3 January 2019

Incidence rate and risk factors of early repolarization in patients with growth hormone-secreting pituitary adenoma: a cohort study
Chen Z, Hu B, Feng Y, Wang Z, Jiang X, Cheng Y, He D, Zhu D, Xiao Z, Wang H, Mao Z
Therapeutics and Clinical Risk Management 2019, 15:65-72
Published Date: 28 December 2018

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database
Inada A, Hosohata K, Oyama S, Niinomi I, Mori Y, Yamaguchi Y, Uchida M, Iwanaga K
Therapeutics and Clinical Risk Management 2019, 15:59-64
Published Date: 24 December 2018

Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension
Wei Z, Wei F, Shao Z, Su G, Qi X, Zhang Y
Therapeutics and Clinical Risk Management 2019, 15:45-57
Published Date: 24 December 2018

Is correction of segmental kyphosis necessary in single-level anterior cervical fusion surgery? An observational study

Lu J, Sun C, Bai J, Tian S, Zhang B, Tian D, Kong L
Therapeutics and Clinical Risk Management 2019, 15:39-44
Published Date: 19 December 2018


Sex differences in clinical characteristics and 1-year outcomes of young ischemic stroke patients in East China


Geng C, Lin Y, Tang Q, Tang Y, Wang X, Zhou JS, Yang J, Zheng D, Zhang YD
Therapeutics and Clinical Risk Management 2019, 15:33-38
Published Date: 19 December 2018

Dose-independent influence of metoprolol on cardiac and motor functions, QoL, and mental status in Chinese patients with CHF
Zhang Q, Shu Q, Wu L, Zhang R, Meng Y
Therapeutics and Clinical Risk Management 2019, 15:23-31
Published Date: 18 December 2018

Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis
Suzuki T, Nakamura Y, Kato H
Therapeutics and Clinical Risk Management 2019, 15:15-22
Published Date: 18 December 2018

Bibliometric analysis of global research on the rehabilitation of spinal cord injury in the past two decades
Liu X, Liu N, Zhou M, Lu Y, Li F
Therapeutics and Clinical Risk Management 2019, 15:1-14
Published Date: 17 December 2018